{
    "2019-10-31": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Top Analyst Reports for Citigroup, Novo Nordisk & BP",
                "features": {
                    "keywords": [
                        "Citigroup",
                        "Novo Nordisk",
                        "BP",
                        "analyst reports"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "healthcare",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Can Novo Nordisk A/S's (CPH:NOVO B) ROE Continue To Surpass The Industry Average?",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "ROE",
                        "industry average"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}